Get the Stockscreener App
177.31
2.76%
4.77
Pre-market:
178.40
1.09
+0.61%
Overview
News
Price History
Option Chain
Financials
Why EFX Down?
Discussions
Forecast
Stock Split
Dividend History
Equifax Inc stock is traded at $177.31, with a volume of 1.98M.
It is up +2.76% in the last 24 hours and up +11.88% over the past month.
Along with Experian and TransUnion, Equifax is one of the leading credit bureaus in the United States. Equifax's credit reports provide credit histories on millions of consumers, and the firm's services are critical to lenders' credit decisions. In addition, about 40% of the firm's revenue comes from Workforce Solutions, which provides income verification and employer human resources services. Equifax generates about 25% of its revenue from outside the United States.
See More
Previous Close:
$172.54
Open:
$175.35
24h Volume:
1.98M
Relative Volume:
1.10
Market Cap:
$20.83B
Revenue:
$6.28B
Net Income/Loss:
$703.80M
P/E Ratio:
31.23
EPS:
5.6784
Net Cash Flow:
$1.14B
1W Performance:
-1.54%
1M Performance:
+11.88%
6M Performance:
-14.77%
1Y Performance:
-28.00%
1-Day Range:
$174.73
$180.72
1-Week Range:
$155.00
$180.72
52-Week Range:
$150.75
$271.84
Equifax Inc Stock (EFX) Company Profile
Name
Equifax Inc
Sector
Industry
Phone
(404) 885-8000
Address
1550 PEACHTREE ST NW, ATLANTA, GA
Compare EFX vs VRSK, BAH, FCN, HURN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EFX
Equifax Inc
|
177.31 | 20.27B | 6.28B | 703.80M | 1.14B | 5.6784 |
VRSK
Verisk Analytics Inc
|
206.66 | 26.38B | 3.10B | 910.20M | 1.13B | 6.5659 |
BAH
Booz Allen Hamilton Holding Corp
|
71.64 | 8.70B | 11.22B | 845.00M | 951.00M | 6.8984 |
FCN
Fti Consulting Inc
|
161.88 | 4.88B | 3.87B | 266.68M | 255.97M | 8.4148 |
HURN
Huron Consulting Group Inc
|
116.51 | 1.89B | 1.75B | 103.75M | 103.64M | 5.8551 |
Equifax Inc Stock (EFX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-16-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Resumed | BofA Securities | Buy |
| Oct-13-25 | Initiated | Oppenheimer | Outperform |
| Oct-01-25 | Initiated | Seaport Research Partners | Neutral |
| Jul-10-25 | Initiated | BMO Capital Markets | Market Perform |
| Jun-23-25 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-10-25 | Resumed | BofA Securities | Buy |
| Apr-04-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-20-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Mar-14-25 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Feb-11-25 | Downgrade | Argus | Buy → Hold |
| Dec-16-24 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Dec-12-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-12-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-01-24 | Initiated | UBS | Buy |
| Sep-19-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Aug-13-24 | Initiated | Wells Fargo | Overweight |
| Jul-09-24 | Initiated | Wolfe Research | Outperform |
| Feb-13-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-11-24 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Jan-08-24 | Upgrade | BofA Securities | Underperform → Buy |
| Jan-04-24 | Reiterated | Needham | Buy |
| Dec-19-23 | Initiated | Oppenheimer | Outperform |
| Dec-18-23 | Upgrade | Jefferies | Hold → Buy |
| Dec-15-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-08-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-20-23 | Initiated | Citigroup | Buy |
| Jul-24-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-06-23 | Initiated | Exane BNP Paribas | Underperform |
| Nov-15-22 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Oct-21-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-19-22 | Downgrade | Jefferies | Buy → Hold |
| Aug-16-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-15-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-13-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-21-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-30-22 | Initiated | Deutsche Bank | Hold |
| Mar-11-22 | Resumed | BofA Securities | Neutral |
| Jan-31-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jan-27-22 | Upgrade | Truist | Hold → Buy |
| Jan-24-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-05-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-22-21 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Oct-22-21 | Upgrade | Argus | Hold → Buy |
| Oct-15-21 | Resumed | Evercore ISI | Outperform |
| Jul-23-21 | Reiterated | Goldman | Neutral |
| Jul-08-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-15-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Dec-11-20 | Upgrade | Stifel | Hold → Buy |
| Dec-08-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-07-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Oct-06-20 | Initiated | Needham | Buy |
| Jul-10-20 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Jun-09-20 | Downgrade | SunTrust | Buy → Hold |
| May-15-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-06-20 | Downgrade | Argus | Buy → Hold |
| Mar-13-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-02-20 | Upgrade | Exane BNP Paribas | Underperform → Outperform |
| Jan-17-20 | Upgrade | Argus | Hold → Buy |
| Nov-22-19 | Initiated | Jefferies | Buy |
| Mar-15-19 | Initiated | Exane BNP Paribas | Underperform |
| Feb-05-19 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-07-18 | Resumed | Credit Suisse | Outperform |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Oct-23-18 | Resumed | BofA/Merrill | Underperform |
| Apr-10-18 | Initiated | BofA/Merrill | Underperform |
| Dec-14-17 | Downgrade | Barclays | Overweight → Equal Weight |
View All
Equifax Inc Stock (EFX) Latest News
EFX|Equifax Inc|Price:177.330|Chg%:+4.790 - TradingKey
Daily Brief Industrials: Deutsche Lufthansa , BYD Company, Raytheon Technologies , Lockheed Martin, Union Pacific, Honeywell International, Equifax Inc, LHN, Croma Security Solutions Group, Comfort Systems Usa and more - Smartkarma
Daily Brief Health Care: Apnimed, Chugai Pharmaceutical, Equifax Inc, Royalty Pharma , Startline, Surgery Partners, Teva Pharmaceutical Sp Adr, Thermo Fisher Scientific Inc and more - Smartkarma
Daily Brief South Korea: SK Hynix, SK Inc, Naver Corp, Chaevi, Equifax Inc and more - Smartkarma
(EFX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Unlocking Equifax (EFX) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance
Equifax: Valuation Has Already Priced In FY2026 Guide (NYSE:EFX) - Seeking Alpha
Equifax Inc (EFX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Equifax Q3 Outlook Pressured by Contract Signing Delays, Oppenheimer Says - Moomoo
Equifax Inc (EFX) Shares Surge 3.5% -- What GF Score of 75 Tells Investors - GuruFocus
Equifax Inc. stock outperforms competitors on strong trading day - MarketWatch
Equifax Launches $1 Billion Senior Notes Offering Featuring Attractive Interest Rates - Kalkine Media
Is Equifax (EFX) Undervalued On Earnings Guidance Buybacks And New Notes? - Sahm
A Quick Look at Today's Ratings for Equifax(EFX.US), With a Forecast Between $179 to $235 - Moomoo
Equifax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
EQUIFAX INC. : WELLS FARGO CUTS TARGET PRICE TO $212 FROM $220 - webull.com
Equifax (EFX) Q2 2026 earnings summary - Quartr
Analysts Are Bullish on These Industrial Goods Stocks: Equifax (EFX), Rocket Lab USA (RKLB) - The Globe and Mail
Equifax, Inc. (EFX) Stock Forecasts - Yahoo Finance
EQUIFAX INC : JP MORGAN CUTS TARGET PRICE TO $210 FROM $230 - Bitget
Equifax Inc Files Pricing Term Sheet For Two-Part Senior Notes Offering Of $1 BillionSEC Filing - TradingView
Equifax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session - Sahm
Is Equifax (EFX) A Bargain As New Debt Clouds Its Valuation? - Yahoo Finance
Is Equifax’s Q2 Results and Círculo de Crédito Deal Altering The Investment Case For Equifax (EFX)? - Sahm
Equifax Says Inflation Is Hitting Lower-Income Consumers - Sahm
EFX Maintained by Morgan Stanley -- Price Target Lowered to $225 - GuruFocus
EFX Maintains by Baird -- Price Target Lowered to $232 - GuruFocus
Deutsche Bank Adjusts Equifax Price Target to $208 From $217, Maintains Buy Rating - Moomoo
EFX Maintains by RBC Capital -- Price Target Lowered to $194.00 - GuruFocus
Morgan Stanley Adjusts Price Target on Equifax to $225 From $243, Maintains Overweight Rating - Moomoo
Barclays Adjusts Price Target on Equifax to $200 From $215, Maintains Equalweight Rating - Moomoo
JPMorgan Adjusts Equifax Price Target to $210 From $230 - Moomoo
Wells Fargo Adjusts Price Target on Equifax to $212 From $220, Maintains Overweight Rating - Moomoo
These Analysts Slash Their Forecasts On Equifax After Q2 Results - Benzinga
BNP Paribas Adjusts Price Target on Equifax to $190 From $185, Maintains Neutral Rating - Moomoo
Needham Adjusts Price Target on Equifax to $245 From $265, Maintains Buy Rating - marketscreener.com
Needham lowers Equifax stock price target to $245 on guidance - Investing.com
Needham lowers Equifax stock price target to $245 on guidance By Investing.com - Investing.com Canada
EQUIFAX INC : NEEDHAM CUTS TARGET PRICE TO $245 FROM $265 - Bitget
Baird Adjusts Price Target on Equifax to $232 From $245, Maintains Outperform Rating - Moomoo
RBC Cuts Price Target on Equifax to $194 From $222, Keeps Outperform Rating - marketscreener.com
Goldman Sachs Adjusts Price Target on Equifax to $182 From $173, Maintains Neutral Rating - marketscreener.com
Equifax Inc at Goldman Sachs U.S. Financial Services Conference Transcript - GuruFocus
Q3 2025 Equifax Inc Earnings Call Transcript - GuruFocus
Equifax (EFX) Reports Q2 Earnings, Misses EPS Expectations - GuruFocus
Q4 2025 Equifax Inc Earnings Call Transcript - GuruFocus
RBC Capital cuts Equifax stock price target on GenAI concerns - Investing.com
RBC Capital cuts Equifax stock price target on GenAI concerns By Investing.com - Investing.com Canada
Equifax Work Number by Equifax Inc.employment data as a growth engine - Ad-hoc-news.de
Equifax (EFX) Stock May Be Above Fair Value Despite The $750M Credit Bureau Deal - Yahoo Finance
Equifax Inc Stock (EFX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.64%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):